Accelerate Diagnostics, Inc. (AXDX)

0.9353 +0.0537 (+6.09%) At close: 04:00PM EDT

Accelerate Diagnostics, Inc.

3950 South Country Club Road
Suite 470 4th Floor
Tucson, AZ 85714
United States
520 365 3100
https://acceleratediagnostics.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 134

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Jack Phillips	CEO, President & Director	595k	N/A	1966
Mr. David Patience	Chief Financial Officer	285.27k	N/A	1986
Mr. Lawrence Michael Mertz	Chief Technology Officer	335.94k	N/A	1963
Ms. Maya Gowri	Senior VP & Head of Operations	N/A	N/A	N/A
Laura Pierson	Investor Relations Officer	N/A	N/A	N/A
Mr. John Meduri	Chief Strategy Officer	N/A	N/A	N/A
Mr. Chris Thode	Senior Vice President of US Commercial	N/A	N/A	N/A
Ms. Rita Boukamel	Senior VP & Head of EMEA	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

Corporate Governance

Accelerate Diagnostics, Inc.’s ISS Governance QualityScore as of April 29, 2024 is 6. The pillar scores are Audit: 10; Board: 3; Shareholder Rights: 3; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.